Clinical Trials Browser

Phase 1 × Carcinoma, Transitional Cell × toripalimab × Clear all

NCT04773951 2021-08-24

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Phase 1 Unknown

DermatologicGenitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma